Screening compound: HAXPCQXLWXNTTK-MRXNPFEDSA-N

Screening compound: HAXPCQXLWXNTTK-MRXNPFEDSA-N
Screening compound: HAXPCQXLWXNTTK-MRXNPFEDSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
HAXPCQXLWXNTTK-MRXNPFEDSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M976-0595

Molecular Formula

C21H25N3O4 (C21 H25 N3 O4)

Compound Name

1-(1-cyclopropanecarbonyl-2,3-dihydro-1H-indol-5-yl)-4-(morpholine-4-carbonyl)pyrrolidin-2-one

IUPAC name

1-(1-cyclopropanecarbonyl-23-dihydro-1H-indol-5-yl)-4-(morpholine-4-carbonyl)pyrrolidin-2-one

SMILES

O=C(C1CC1)N(CC1)c(cc2)c1cc2N(CC(C1)C(N2CCOCC2)=O)C1=O

InChI

InChI=1S/C21H25N3O4/c25-19-12-16(20(26)22-7-9-28-10-8-22)13-24(19)17-3-4-18-15(11-17)5-6-23(18)21(27)14-1-2-14/h3-4,11,14,16H,1-2,5-10,12-13H2/t16-/m1/s1

InChI Key

HAXPCQXLWXNTTK-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD27558409

HAXPCQXLWXNTTK-MRXNPFEDSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with HAXPCQXLWXNTTK-MRXNPFEDSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound HAXPCQXLWXNTTK-MRXNPFEDSA-N?
Check Price and Availability of HAXPCQXLWXNTTK-MRXNPFEDSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of HAXPCQXLWXNTTK-MRXNPFEDSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for HAXPCQXLWXNTTK-MRXNPFEDSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for HAXPCQXLWXNTTK-MRXNPFEDSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of HAXPCQXLWXNTTK-MRXNPFEDSA-N available by request